Linking immunity to atherosclerosis: Implications for vascular pharmacology — A tribute to Göran K. Hansson
- 1 January 2012
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 56 (1-2) , 29-33
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Texas State Higher Education Board
- Swedish Research Council
- Swedish Heart-Lung Foundation
This publication has 46 references indexed in Scilit:
- Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic MiceCirculation, 2011
- T-Cell Activation Leads to Reduced Collagen Maturation in Atherosclerotic Plaques of Apoe−/− MiceThe American Journal of Pathology, 2009
- Interferon-γ and atherosclerosis: Pro- or anti-atherogenic?Cardiovascular Research, 2005
- Immunomodulation of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Oligoclonal T Cell Expansions in Atherosclerotic Lesions of Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Expression of the Macrophage Scavenger Receptor in AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- High Endothelial Cells of Postcapillary Venules Express the Scavenger Receptor in Human Peripheral Lymph NodesScandinavian Journal of Immunology, 1995
- Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury.Journal of Experimental Medicine, 1994
- Immune and inflammatory mechanisms in the development of atherosclerosisHeart, 1993
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983